Andrew Goodman

2.4k total citations
12 papers, 327 citations indexed

About

Andrew Goodman is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Andrew Goodman has authored 12 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Andrew Goodman's work include Breast Cancer Treatment Studies (4 papers), Ocular Oncology and Treatments (3 papers) and Immunotherapy and Immune Responses (2 papers). Andrew Goodman is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Ocular Oncology and Treatments (3 papers) and Immunotherapy and Immune Responses (2 papers). Andrew Goodman collaborates with scholars based in United Kingdom, India and Germany. Andrew Goodman's co-authors include Adrian Murray Brunt, Clare Griffin, J.R. Marsden, Mark Sydenham, Anna Marie P. Young, Janet Dunn, James P. Morden, Stephen Kelly, Judith M. Bliss and Navita Somaiah and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Andrew Goodman

12 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Goodman United Kingdom 8 172 166 70 69 60 12 327
Annette H. Chakera Denmark 14 326 1.9× 103 0.6× 65 0.9× 69 1.0× 23 0.4× 43 523
Elena Tornari Italy 9 244 1.4× 55 0.3× 31 0.4× 42 0.6× 30 0.5× 12 431
Frank J. Bellafiore United States 7 69 0.4× 74 0.4× 96 1.4× 150 2.2× 11 0.2× 11 524
I. H. Liem Netherlands 7 212 1.2× 208 1.3× 154 2.2× 55 0.8× 9 0.1× 9 465
Maura Campitelli Italy 13 85 0.5× 151 0.9× 44 0.6× 113 1.6× 53 0.9× 33 504
R. Jared Weinfurtner United States 9 183 1.1× 124 0.7× 109 1.6× 146 2.1× 12 0.2× 34 452
Andrew O. Wahl United States 15 120 0.7× 82 0.5× 38 0.5× 154 2.2× 135 2.3× 39 545
Ron Koelemij Netherlands 13 197 1.1× 224 1.3× 145 2.1× 122 1.8× 54 0.9× 22 469
B.A.E. Kapteijn Netherlands 8 350 2.0× 143 0.9× 92 1.3× 28 0.4× 13 0.2× 14 485
Joseph Sia Australia 8 143 0.8× 64 0.4× 13 0.2× 112 1.6× 44 0.7× 24 421

Countries citing papers authored by Andrew Goodman

Since Specialization
Citations

This map shows the geographic impact of Andrew Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Goodman more than expected).

Fields of papers citing papers by Andrew Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Goodman. The network helps show where Andrew Goodman may publish in the future.

Co-authorship network of co-authors of Andrew Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Goodman. A scholar is included among the top collaborators of Andrew Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Goodman. Andrew Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nair, Devi G., Anil Rajendra, León A. Feldman, et al.. (2024). TCT-537 Optimization of Access Using Dedicated RF-TSP Devices Increases Efficiency and Consistency of LAAC With Watchman FLX Pro: A Report From a HEAL-LAA Primary Analysis Subset. Journal of the American College of Cardiology. 84(18). B186–B186. 1 indexed citations
2.
Nathan, Paul, Sarah Danson, Jonathan J. Evans, et al.. (2019). SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM). Annals of Oncology. 30. v908–v910. 10 indexed citations
3.
Fernando, Indrajit, S. Bowden, Cassandra Brookes, et al.. (2019). Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. Radiotherapy and Oncology. 142. 52–61. 10 indexed citations
4.
Brunt, Adrian Murray, Duncan Wheatley, John Yarnold, et al.. (2016). Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiotherapy and Oncology. 120(1). 114–118. 149 indexed citations
5.
Nathan, Paul, Piers Gaunt, Keith Wheatley, et al.. (2016). UKMCC-01: A phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma.. Journal of Clinical Oncology. 34(15_suppl). 9542–9542. 27 indexed citations
6.
Morden, James P., Judith M. Bliss, Jane Bayani, et al.. (2015). Abstract P4-11-04: Intrinsic subtypes and BCL2 as predictive and prognostic biomarkers in the TACT2 trial (CRUK/05/019). Cancer Research. 75(9_Supplement). P4–11. 1 indexed citations
7.
Sacco, Joseph J., Paul Nathan, Sarah Danson, et al.. (2013). Sunitinib versus dacarbazine as first-line treatment in patients with metastatic uveal melanoma.. Journal of Clinical Oncology. 31(15_suppl). 9031–9031. 25 indexed citations
8.
Marshall, Ernest, Sarah E. Coupland, Pippa Corrie, et al.. (2012). A randomized phase II study of sunitinib versus dacarbazine in the treatment of patients with metastatic uveal melanoma.. Journal of Clinical Oncology. 30(15_suppl). TPS8605–TPS8605. 1 indexed citations
9.
10.
Goodman, Andrew, et al.. (2008). The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ. World Journal of Surgical Oncology. 6(1). 61–61. 46 indexed citations
11.
Young, Anna Marie P., J.R. Marsden, Andrew Goodman, Andrea Burton, & Janet Dunn. (2001). Prospective Randomized Comparison of Dacarbazine (DTIC) Versus DTIC Plus Interferon-Alpha (IFN-α) in Metastatic Melanoma. Clinical Oncology. 13(6). 458–465. 49 indexed citations
12.
Brunt, Adrian Murray, Andrew Goodman, Robert H. Phillips, M Youle, & Brian Gazzard. (1989). The safety of intravenous chemotherapy and zidovudine when treating epidemic Kaposiʼs sarcoma. AIDS. 3(7). 457–460. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette H. Chakera Breakdown of academic impact, for papers by Elena Tornari Breakdown of academic impact, for papers by Frank J. Bellafiore Breakdown of academic impact, for papers by I. H. Liem Breakdown of academic impact, for papers by Maura Campitelli Breakdown of academic impact, for papers by R. Jared Weinfurtner Breakdown of academic impact, for papers by Andrew O. Wahl Breakdown of academic impact, for papers by Ron Koelemij Breakdown of academic impact, for papers by B.A.E. Kapteijn Breakdown of academic impact, for papers by Joseph Sia
Rankless by CCL
2026